Invention Grant
- Patent Title: Method of preventing β cell disruption in pancreatic Langerhans' islets
- Patent Title (中): 预防胰腺胰岛的β细胞破裂的方法
-
Application No.: US10553672Application Date: 2004-04-15
-
Publication No.: US07662366B2Publication Date: 2010-02-16
- Inventor: Yoshiki Kawabe , Yuichiro Adachi
- Applicant: Yoshiki Kawabe , Yuichiro Adachi
- Applicant Address: JP Tokyo
- Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee Address: JP Tokyo
- Agency: Browdy and Neimark, PLLC
- Priority: JP2003-110561 20030415
- International Application: PCT/JP2004/005397 WO 20040415
- International Announcement: WO2004/091661 WO 20041028
- Main IPC: A61K45/00
- IPC: A61K45/00 ; A61K38/19
Abstract:
The object of the present invention is to provide a method for treating diabetes which is simple, safe and effective when compared to conventional diabetes treatment. The administration of one or more stem cell-recruiting factors allows a simple and safe repair of disrupted β-cells in pancreatic Langerhans' islets. Thus, the therapeutic agent of the present invention which comprises one or more stem cell-recruiting factors as active ingredients is useful for diabetes treatment. Examples of such a stem cell-recruiting factor include colony-stimulating factors such as G-CSF.
Public/Granted literature
- US20070098680A1 Agent for treating diabetes mellitus Public/Granted day:2007-05-03
Information query
